Comparison of Outcomes Between the Use of Silverlon® Dressing and AQUACEL® AG Dressing Post Cardiac Device Implant

This is a single center, prospective, 2-arm randomized, non-blinded study. A total of 100
participants will be assigned to the Silverlon arm and 100 to the AQUACEL AG arm.

The number of procedures to implant CIED has risen in recent years. With this rise has also
brought a rise in post-procedure infections. Infections will happen and there is a continued
need to improve all aspects of the surgery and post-operative care. Wound coverage with
appropriate dressings is one aspect that needs to be studied in CIED implant patients.
Silverlon and AQUACEL AG are two options of dressings available for these patients. This
study will look to see if one of the two is a better option for post-operative CIED implant
patients.

Inclusion Criteria:

- Patients who are scheduled for a CIED implant, generator change, or upgrade at the
University of Kansas Hospital

- Able to give informed consent

Exclusion Criteria:

- Patients who are already on antibiotics for another reasons

- Immunocompromised patients such as those on immunosuppressant's and HIV positive
patients

- Patients who are post device explant for lead infection

- Patients with an allergy to adhesive, silver or an allergy to the dressing(s) or their
components